Searchable abstracts of presentations at key conferences in endocrinology

ea0016p492 | Obesity | ECE2008

Metabolic and hormonal patterns in men under the age 40 years with obesity and metabolic syndrome

Goncharov Nikolai , Katsya Gulinara , Chagina Nina

Objectives: To assess the androgens profile (total testosterone (TT),free testosterone (fT), SHBG, and DHEA-sulphate), cortisol, aldosterone, insulin, and leptin in patients with obesity (OB), metabolic syndrome (MS) and healthy men (HM).Subjects and methods: Group 1: 26 men with obesity, age 30±6 years. BMI 27–35 kg/m2. Group 2: 34 men with MS, age 31±6 yrs. BMI 30–36 kg/m2. Group 3: 20 healthy men, age 28±...

ea0016p422 | Neuroendocrinology | ECE2008

Macroprolactinaemia in men

Dzeranova Larisa K , Giniyatullina Ekaterina N , Rozhinskaya Ludmila Y , Goncharov Nikolai P , Dobracheva Anna D

Background: It is known women suffer from macroprolactinaemia more frequently than men. Often men with unclear genesis of hyperprolactinaemia have normal or a little depressed Testosterone level. High macroprolactin level in blood serum can explain this type of hyperprolactinaemia.Materials and methods: Sixty-four men with hyperprolactinaemia (Prl >600 mU/l) were studied. Clinical, biochemical and MRI methods were used. Prl and Testosterone levels we...

ea0014p549 | (1) | ECE2007

Macroprolactin: the clinically and diagnostically importance

Dzeranova Larisa K , Giniatullina Ekaterina N , Goncharov Nikolai P , Dobracheva Anna D , Kolesnikova Galina S

Recently, the phenomenon of macroprolactinaemia has manifested itself into a great interest for physicians. This problem forces both physicians and patient to waste sizeable resources, and can lead to iatrogenic and unjustified emotional stress and further material losses. At the same time the problem of differential diagnostics of pseudoprolactinomas and true prolactinomas remains challenging. The purpose of the present study was to determine the clinic-analytical repercussio...

ea0014p256 | (1) | ECE2007

HRT in treatment of dislipidemia in women with hypogonadotropic hypogonadism

Zektser Vita , Ilovayskaya Irena , Iliyn Aleksandr , Goncharov Nikolay , Melnichenko Galina

Hypoestrogenemia is associated with dislipidemia and is an independent risk factor for cardiovascular diseases in postmenopausal women. However, there is a cohort of young women with gonadal steroid deficit caused by the disorders of central regulation. Twenty women with hypogonadotropic hypogonadism (HH) were included in group 1. (median age - 29 years and 3 months, median duration of amenorhea - 5 years 3 months, mean BMI - 24.6±6.05 kg/cm2. Women were examined before a...

ea0032p685 | Neuroendocrinology | ECE2013

Antipsychotic-induced hyperpolactinemia: clinical particulars and relation to sexual dysfunction

Yunilainen Olga , Starostina Elena , Dzeranova Larisa , Kolesnikova Galina , Kazia Gulnara , Goncharov Nikolay , Dedov Ivan

Objectives: To assess prevalence of antipsychotic-induced hyperpolactinemia (AIH) in psychiatric in-patients and to describe its clinical characteristics and association of AIH with sexual function.Methods: A cross-sectional study in 143 consecutive psychiatric in-patients (F/M=65/78), mostly with schizophrenia (93%), currently taking antipsychotics. The patients were screened for serum prolactin, sex hormones, gonadotropin levels and macroprolactin. For...

ea0022p484 | Female reproduction | ECE2010

Metabolic changes associated with hypogonadotropic hypogonadism in women of reproductive age and effect of HRT

Ilovayskaya Irena , Zektser Vita , Iljin Alexandr , Goncharov Nikolay , Melnichenko Galina , Dedov Ivan

We examined 56 normoprolactinemic women of reproductive age (18–45 y.o.) with isolated hypogonadotropic hypogonadism (group 1) initially and on treatment with 2 mg of 17β-estradiol and 10 mg of dydrogesterone in sequenced manner (HRT), duration of HRT was from 18 to 42 (median 36) months; 45 healthy women (20–38 y.o.) were included in control group 2.Initially hypercholesterolemia was observed in 50% of cases in group 1 and 6.6% in group 2...

ea0061p005 | (1) | OU2019

Metabolic health and different body composition phenotypes in a Maltese cohort

Agius Rachel , Pace Nikolai , Fava Stephen

It is known that a subset of obese individuals do not exhibit features of the metabolic syndrome (Met-S); these are referred to as being metabolically healthy obese (MHO) individuals. Conversely there are other individuals who although have a normal BMI are insulin resistant and exhibit some of the features of the Met-S and are termed as being metabolically unhealthy normal weight (MUHNW) individuals. This study aims to identify the prevalence of metabolic health among a diffe...

ea0020p571 | Neuroendocrinology, Pituitary and Behaviour | ECE2009

Macroprolactinemia in patients with pituitary adenomas

Dzeranova LK , Giniyatullina EN , Barmina II , Dobracheva AD , Goncharov NP

Elevated macroprolactin level is one of the reason of misdiagnosis and mismanagement of hyperprolactinamia. About 10% of population have incidentalomas and it also can combine with increasing of prolactin (Prl).Three hundred and thirty patients with hyperprolactinemia (Prl>600 mU/l) were studied: 192 women and 138 men in age of 30 (25; 39) and 35 (29;46) years respectively. Clinical, biochemical and MRI methods were used. Prl, LH, FSH and Testosteron...

ea0037ep702 | Pituitary: basic and neuroendocrinology | ECE2015

Molecular analysis of miRNA expression profiles in AIP mutation positive somatotropinomas

Falk Nikolai , Daly Adrian , Beckers Albert , Pellegata Natalia

Germline mutations in the aryl hydrocarbon receptor interacting protein gene (AIP) predispose to pituitary adenomas in young patients, often presenting as familial isolated pituitary adenoma (FIPA) kindreds. Pituitary adenomas in patients with AIP mutations (AIPmut) are usually somatotropinomas, which are more aggressive and have poorer responses to somatostatin analogues than their non-mutated counterparts. Given the rarity of this condition, the molecular pathogenesis of the...

ea0035p4 | Adrenal cortex | ECE2014

ACTH-secreting pheochromocytoma: case report

Krylov Vadim , Dobreva Ekaterina , Kuznetsov Nikolai , Latkina Nona , Marova Evgeniya

Introduction: We report the clinical presentation of pheochromocytoma with Cushing’s syndrome due to ectopic production of ACTH, and assess the histopathological diagnosis, treatment modality and prognostic factors compared with the literature.Results: Cushing’s Syndrome due to ectopic ACTH production is uncommon and due to pheochromocytoma is extremely rare. We discuss the case of a 50-year-old female who initially presented with vague, non-sp...